WallStreetZenWallStreetZen

NYSEMKT: NBY
Novabay Pharmaceuticals Inc Earnings Dates, Reports, Calls

OverviewEarnings
RevenueDividendOwnership
Novabay Pharmaceuticals earnings were $2.7M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest NBY earnings report on Mar 31, 2025 announced Q1 2025 earnings of $7.7M, down 732.8% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, NBY reported annual earnings of -$8.6M, with -49.3% growth.

NBY earnings history

Current Revenue
$7.2M
Current Earnings
$2.7M
Current Profit Margin
37.1%

NBY Return on Equity

Current Company
163.6%
Current Industry
-60.2%
Current Market
31.5%
NBY's Return on Equity (163.6%)... subscribe to Premium to read more.
High Return on Equity Performance

NBY undefined

Current Company
50.4%
Current Industry
-2.5%
NBY is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when NBY announces earnings.

NBY undefined

Current Company
53.8%
Current Industry
5.8%
NBY has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

NBY vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
NBY$4.09M$2.66MN/A$0.91
SPRC$1.96M$1.74MN/A-$0.35
THAR-$12.47M-$12.48MN/A-$7.88
JAGX-$37.87M-$39.73MN/A-$152.39
XRTX-$629.97k-$709.35kN/A-$0.16
View Top Biotech Stocks

Novabay Pharmaceuticals Earnings Reports & History FAQ

What were Novabay Pharmaceuticals's earnings last quarter?

On NBY's earnings call on Invalid Date, Novabay Pharmaceuticals (NYSEMKT: NBY) reported Q1 2025 earnings per share (EPS) of $1.44, up 104.81% year over year. Total NBY earnings for the quarter were $7.67 million. In the same quarter last year, Novabay Pharmaceuticals's earnings per share (EPS) was -$29.95.

If you're new to stock investing, here's how to buy Novabay Pharmaceuticals stock.

Is Novabay Pharmaceuticals profitable or losing money?

As of the last Novabay Pharmaceuticals earnings report, Novabay Pharmaceuticals is currently profitable. Novabay Pharmaceuticals's net profit (also called net income) for the twelve months ending Mar 31, 2025 was $3.66 million, a 132.16% decrease year over year.

What was NBY's earnings growth in the past year?

As of Novabay Pharmaceuticals's earnings date in Invalid Date, Novabay Pharmaceuticals's earnings has grown year over year. NBY earnings in the past year totalled $2.66 million.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.